Glycopyrrolate

ANDA 85563, held by Watson Labs. Glycopyrrolate.

As of Nov 15, 2026, ANDA 85563 (Glycopyrrolate), held by Watson Labs, was first approved by FDA on Sep 16, 1985, with 1 approved supplement and 0 published complete response letters.

First approved: Sep 16, 1985
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Sep 16, 1985	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Glycopyrrolate2MG · tablet;oral	Glycopyrrolate	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Sep 16, 1985	Original application	Approved	None posted
Sep 9, 1983	Supplement 13Manufacturing	Approved	None posted

Identifiers

Application: ANDA 85563
Drugs@FDA: Overview at FDA
Company: Watson Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters